Ongoing price erosion in key products remains a lingering concern for Dr. Reddy's and therefore, Goldman Sachs has cut its ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...

In the past year or so, people have been increasingly outspoken about suspicions that their injectors are “watering down” ...

A 52-week extension study showed that the drug continues to maintain favorable body composition with no safety issues.

Novo Nordisk (CPSE:NOVO B) reported strong phase 3 trial results for its oral semaglutide in children and adolescents with type 2 diabetes. The company plans to file for US and EU label expansions to ...

Pediatric approval leveraged CupidKids pharmacokinetic bridging and safety assessments, with adverse events consistent across ...

Researchers based in the West Midlands have been funded to study the affects of weight-loss injections on patients with ...

Learn prompt engineering with this practical cheat sheet covering frameworks, techniques, and tips to get more accurate and ...

As regulators examine the on-body injector used with isatuximab in multiple myeloma, Sikander Ailawadhi, MD, provides commentary on frequently asked questions. The European Medicines Agency’s ...

Oral semaglutide lowered HbA1c vs placebo in a phase 3 trial in adolescents with type 2 diabetes, pending full data and ...

How far would you go to become a “Chad” — or even just a “high-tier normie”? Spend five minutes scrolling “looksmaxxing” ...

For three decades, Chloë Sevigny has cut a singular path, both on screen and in fashion, building a body of work that feels ...